Impact of type 2 diabetes on left ventricular geometry and diastolic function in hypertensive patients with chronic kidney disease

被引:9
|
作者
Nardi, E. [1 ]
Palermo, A. [1 ]
Mule, G. [1 ]
Cusimano, P. [1 ]
Cottone, S. [2 ]
Cerasola, G. [1 ]
机构
[1] Univ Palermo, Excellence Ctr European Soc Hypertens, Dipartimento Med Interna Malattie Cardiovasc & Ne, Cattedra Med Interna, I-90146 Palermo, Italy
[2] Univ Palermo, Excellence Ctr European Soc Hypertens, Dipartimento Med Interna Malattie Cardiovasc & Ne, Cattedra Nefrol, I-90146 Palermo, Italy
关键词
left ventricular hypertrophy; diabetes; chronic kidney disease; diastolic dysfunction; heart diseases; RENAL-INSUFFICIENCY; HEART; HYPERTROPHY; ECHOCARDIOGRAPHY; DYSFUNCTION; CREATININE; PREDICTION; MORTALITY; ADULTS; MASS;
D O I
10.1038/jhh.2010.96
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Left ventricular hypertrophy (LVH) and diastolic dysfunction are very common in patients with chronic kidney disease (CKD). Aim of this study was to evaluate the impact of type 2 diabetes on LV geometry and diastolic function in hypertensive patients with CKD. We enrolled 288 Caucasian subjects with hypertension and CKD; of them, 112 had diabetes. Patients with cardiovascular (CV) diseases, glomerular filtration rate (GFR) >60 ml min(-1) per 1.73 m(2), dialysis treatment and other major non-CV diseases were excluded. All patients underwent routine biochemical analyses and echocardio-graphic examination with tissue Doppler imaging (TDI). Patients with diabetes had significantly higher LV wall thicknesses (P = 0.0001), relative wall thickness (RWT) (P = 0.0001) and left atrium volume index (P = 0.03), when compared with patients without diabetes. Further, diabetic patients had very high prevalence of concentric LVH. Em, evaluated by TDI, was significantly lower in patients with diabetes (P = 0.005). However, the difference lost statistical significance after correction by analysis of covariance for RWT. Multiple stepwise linear regression analysis showed that the variables independently associated with Em were: age (beta 0.364; P = 0.0001), GFR (beta 0.101; P = 0.019), and the presence of diabetes (beta 0.166; P = 0.002). Our study showed that in hypertensive patients with CKD the presence of diabetes is associated with increased LV-wall thicknesses and concentric geometry; further, diabetes together with renal function (GFR) is associated with worse diastolic function, independently of potential confounders, such as age, gender, body mass index and blood pressure. Journal of Human Hypertension (2011) 25, 144-151; doi:10.1038/jhh.2010.96; published online 14 October 2010
引用
收藏
页码:144 / 151
页数:8
相关论文
共 50 条
  • [31] Effect of canagliflozin on left ventricular diastolic function in patients with type 2 diabetes
    Matsutani, Daisuke
    Sakamoto, Masaya
    Kayama, Yosuke
    Takeda, Norihiko
    Horiuchi, Ryuzo
    Utsunomiya, Kazunori
    CARDIOVASCULAR DIABETOLOGY, 2018, 17
  • [32] Serum Osteoprotegerin Is an Independent Marker of Left Ventricular Hypertrophy, Systolic and Diastolic Dysfunction of the Left Ventricle and the Presence of Pericardial Fluid in Chronic Kidney Disease Patients
    Romejko, Katarzyna
    Rymarz, Aleksandra
    Szamotulska, Katarzyna
    Bartoszewicz, Zbigniew
    Niemczyk, Stanislaw
    NUTRIENTS, 2022, 14 (14)
  • [33] Associations of Traditionally Determined Left Ventricular Mass Indices and Hemodynamic and Non-Hemodynamic Components of Cardiac Remodeling with Diastolic and Systolic Function in Patients with Chronic Kidney Disease
    Hsu, Hon-Chun
    Tade, Grace
    Robinson, Chanel
    Dlongolo, Noluntu
    Teckie, Gloria
    Solomon, Ahmed
    Woodiwiss, Angela Jill
    Dessein, Patrick Hector
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (13)
  • [34] Impact of baseline left ventricular ejection fraction and body mass index on the effect of 24-week Ipragliflozin treatment on left ventricular diastolic function in patients with type 2 diabetes and chronic kidney disease: insights from the PROCEED trial
    Hiroki Teragawa
    Atsushi Tanaka
    Kanae Takahashi
    Chikage Oshita
    Yuko Uchimura
    Nozomu Kamei
    Hiroyuki Hirai
    Michio Shimabukuro
    Isao Taguchi
    Yosuke Okada
    Koichi Node
    Cardiovascular Diabetology, 24 (1)
  • [35] Impact of Definitions of Left Ventricular Hypertrophy on Left Ventricular Remodeling Findings in Patients with Predialysis Chronic Kidney Disease: An Echocardiographic Study
    Chen, Shih-Jen
    Liu, Ping-Chang
    Yang, Ning-I
    Cheng, Chi-Wen
    Wu, I-Wen
    Wu, Mai-Szu
    Cherng, Wen-Jin
    Hung, Ming-Jui
    ACTA CARDIOLOGICA SINICA, 2012, 28 (01) : 42 - 52
  • [36] Impact of Hypertension on Left Ventricular Geometry and Diastolic Function in Africa: Results from the Population-Based TAnve Health (TAHES) Cohort Study
    Vandroux, David
    Aboyans, Victor
    Houehanou, Yessito Corine
    Chastaingt, Lucie
    Saka, Dominique
    Sonou, Arnaud
    Amidou, Salmane
    Houinato, Dismand
    Preux, Pierre Marie
    Magne, Julien
    Lacroix, Philippe
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 211 : 275 - 281
  • [37] Plasma Glucose Levels and Left Ventricular Diastolic Function in Nondiabetic Hypertensive Patients
    Catena, Cristiana
    Colussi, GianLuca
    Martinis, Flavia
    Pezzutto, Francesca
    Sechi, Leonardo A.
    AMERICAN JOURNAL OF HYPERTENSION, 2013, 26 (11) : 1353 - 1361
  • [38] Diastolic Function and Ambulatory Hypertension in Children With Chronic Kidney Disease
    Mitsnefes, Mark M.
    Xu, Yunwen
    Ng, Derek K.
    Hill, Garick
    Kimball, Thomas
    Furth, Susan L.
    Warady, Bradley A.
    HYPERTENSION, 2021, 78 (05) : 1347 - 1354
  • [39] The impact of diabetes duration on left ventricular diastolic function and cardiovascular disease
    Kim, Yujeong
    Shin, Mi-Seung
    Kim, Yeun Sun
    Kang, Woong Chol
    Kim, Bong Roung
    Moon, Jeonggeun
    Chung, Wook-Jin
    Ahn, Tae Hoon
    Shin, Eak Kyun
    POSTGRADUATE MEDICAL JOURNAL, 2012, 88 (1038) : 189 - 193
  • [40] Impact of valvular regurgitation on left ventricular geometry and function in hypertensive patients with left ventricular hypertrophy: the LIFE study
    J Kontos
    V Papademetriou
    K Wachtell
    V Palmieri
    J E Liu
    E Gerdts
    K Boman
    M S Nieminen
    B Dahlöf
    R B Devereux
    Journal of Human Hypertension, 2004, 18 : 431 - 436